Physician profile
Travis C Lipscomb
NPI 1932872777
$1,402.56
in general payments reported to CMS, 2019-2025
14 companies · $697 in 2025
The $697 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $224 · 2023: $162 · 2024: $319 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $441.66 | 2022-2025 | Miebo, Xiidra, Infuse |
| Alcon Vision LLC | $295.51 | 2022-2025 | Tryptyr, Precision 1, Precision7 |
| Coopervision INC. | $199.58 | 2022-2025 | Myday Contact Lens, Clariti Contact Lens, Onefit Contact Lens |
| Abbvie INC. | $113.47 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $58.54 | 2024-2025 | Tecnis Simplicity |
| Sun Pharmaceutical Industries INC. | $49.55 | 2024-2025 | |
| Oyster Point Pharma, INC. | $41.82 | 2022-2025 | Tyrvaya, Ryzumvi |
| Johnson & Johnson Vision Care, INC. | $41.31 | 2023 | Acuvue |
| Apellis Pharmaceuticals, INC. | $40.49 | 2025 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $38.42 | 2025 | Xdemvy |
| New World Medical,INC. | $35.65 | 2024 | Kahook Dual Blade, Ahmed Glaucoma Valve, Clearpath |
| Harrow Eye, LLC | $17.04 | 2024 | Vevye |
| Abb Con-Cise Optical Group LLC | $14.78 | 2025 | Contact Lens |
| Thea Pharma INC. | $14.74 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Lipscomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.